# SMAD2, SMAD3 AND TGF-β GENE EXPRESSION IN URGE URINARY INCONTINENCE

> **NCT04525105** · — · COMPLETED · sponsor: **Muğla Sıtkı Koçman University** · enrollment: 24 (actual)

## Conditions studied

- SMAD2
- SMAD3
- TGF-β
- Pelvic Organ Prolapse
- Urge Urinary Incontinence

## Interventions

- **GENETIC:** SMAD2

## Key facts

- **NCT ID:** NCT04525105
- **Lead sponsor:** Muğla Sıtkı Koçman University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-01
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04525105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04525105, "SMAD2, SMAD3 AND TGF-β GENE EXPRESSION IN URGE URINARY INCONTINENCE". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04525105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*